American Capital Advisory’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.59K Buy
54
+15
+38% +$1.34K ﹤0.01% 430
2026
Q1
$2.8K Buy
39
+7
+22% +$539 ﹤0.01% 479
2025
Q4
$2.54K Buy
32
+8
+33% +$631 ﹤0.01% 432
2025
Q3
$1.81K Sell
24
-1
-4% -$69 ﹤0.01% 446
2025
Q2
$1.73K Buy
25
+14
+127% +$918 ﹤0.01% 424
2025
Q1
$746 Sell
11
-29
-73% -$1.74K ﹤0.01% 461
2024
Q4
$1.8K Hold
40
﹤0.01% 403
2024
Q3
$2.52K Hold
40
﹤0.01% 385
2024
Q2
$3.16K Sell
40
-224
-85% -$14K ﹤0.01% 333
2024
Q1
$19.6K Buy
264
+224
+560% +$17.1K 0.02% 201
2023
Q4
$3.16K Buy
+40
New +$2.85K ﹤0.01% 333

Other funds holding CVS

American Capital Advisory's CVS Position: Q2 2026 in Review

American Capital Advisory increased its CVS Health (CVS) stake by 38% in Q2 2026, buying an estimated $1.34K and bringing the position to 54 shares worth $5.59K. The position accounts for ﹤0.01% of the portfolio, ranked #430.

American Capital Advisory first reported a position in CVS in Q4 2023 and has held it in 11 quarters since. The position peaked at $19.6K in Q1 2024. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • American Capital Advisory held 54 shares of CVS Health worth $5.59K as of Q2 2026.
  • American Capital Advisory bought 15 CVS Health shares in Q2 2026, an estimated $1.34K.
  • CVS Health made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #430 holding.
  • American Capital Advisory first reported a position in CVS Health in Q4 2023 and has held it in 11 quarters since.
  • American Capital Advisory's CVS Health position peaked at $19.6K in Q1 2024.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.